AZA.O. Zakrutko

A.O. Zakrutko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A.O. Zakrutko has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Current understanding of the etiopathogenesis of COVID-19 and radiological diagnosis of complications (literature review)

    by A.O. Zakrutko

    Background. Coronavirus disease 2019 (COVID-19) remains clinically relevant because of its multisystem involvement, possible prolonged post-infectious manifestations, and the need for correct interpretation of thoracic imaging findings. Expanding knowledge of disease pathogenesis requires a concurrent reassessment of the role of imaging methods in diagnosing pulmonary complications. Aim. To analyze current scientific literature on the etiopathogenesis of coronavirus disease 2019, compare the capabilities of chest radiography and computed tomography, and identify characteristic computed tomography features of lung parenchymal involvement in coronavirus disease 2019. Materials and Methods. A literature review of publications from 2020–2026 indexed in Scopus and Web of Science and published in professional medical journals was performed using system analysis. Search terms concerned the etiopathogenesis of coronavirus disease 2019, radiological diagnosis, computed tomography, radiography, and "ground-glass" opacity. The study was conducted as the author's private initiative, without grant support or state registration of the research topic. Research Ethics. Publications whose authors reported compliance with applicable bioethical requirements were selected for the review. Results. Evidence on the systemic nature of coronavirus disease, immune-inflammatory and endothelial mechanisms of injury, and possible persistence of viral components in the gastrointestinal tract was summarized. Computed tomography detects early and subtle parenchymal abnormalities better than plain radiography but lacks sufficient etiological specificity. The most characteristic computed tomography findings are bilateral peripheral "ground-glass" opacities, consolidation, and the "crazy-paving" pattern. The extent and severity of abnormalities may have prognostic value, although findings depend on clinical context, timing of imaging, and study population. COVID-19 findings partly overlap with other viral pneumonias; therefore, differential diagnosis requires integration of imaging with clinical and laboratory data. Conclusions. Imaging complements laboratory diagnosis of coronavirus disease 2019 but does not replace viral ribonucleic acid detection. Computed tomography is most informative for detailed assessment of lung parenchyma and disease extent, whereas radiography retains advantages in availability and portability. Keywords: medical radiology, computed tomography, radiography, "ground-glass" opacity.

  • Open Access

    Clinical and Radiological Features of Lung Involvement in COVID-19 (SARS-CoV-2) and Influenza A(H1N1)pdm09

    by V.P. Starenkyi, A.O. Zakrutko, H.I. Hradil

    Background. SARS-CoV-2 (COVID-19) and influenza A(H1N1)pdm09 are associated with the development of viral pneumonia and acute respiratory distress syndrome (ARDS), contributing to high mortality. Differences in clinical and radiological characteristics of lung involvement in these infections require further investigation. Objective. To determine the clinical and radiological features of lung involvement in patients with COVID-19 and influenza A(H1N1)pdm09 complicated by communityacquired pneumonia, and to assess the correlation between the extent of lung parenchymal involvement and disease severity. Materials and Methods. A total of 113 medical records from 2021–2023 were analyzed: 75 patients with COVID-19, 38 with other viral pneumonias, and 30 with influenza A(H1N1)pdm09 (2009–2016). The extent of lung involvement was assessed using the RALE score and CT-based criteria (CT-1–CT-4). Results. In patients with COVID-19, bilateral lung involvement was observed in 92.3% of cases, peripheral distribution of infiltrates in 59%, and ground-glass opacities in all patients. Consolidations were detected in 43.5% of cases. In patients with influenza A(H1N1)pdm09 and other viral pneumonias, imaging findings were similar but predominantly peribronchovascular in distribution. No reversed halo sign or cavitation was observed. The RALE score ranged from 9 to 48 points (mean 29 ± 3.707). No correlation was found between RALE score and disease duration. No association was identified between the extent of lung involvement and COVID-19 severity. Conclusions. The findings indicate differences in radiological patterns of lung involvement between COVID-19 and influenza A(H1N1)pdm09. The RALE score is an effective tool for standardized assessment of disease severity.

  • Open Access

    The morphofunctional state of the hematoalveolar barrier of the lungs in COVID-19 patients compared to pandemic influenza

    by O.P. Lukashova, H.I. Hradil, В.п. Старенький, A.M. Nasonova, А.о. Закрутько, I.M. Teslenko, Г.і. Граділь

    Background. It is known that viral infections, such as pandemic influenza A(H1N1) and COVID-19, are characterized by acute respiratory distress syndrome, which in some cases is accompanied by high mortality. It has also been established that diffuse alveolar damage (DAD) is common to both influenza A and COVID-19. However, there are some differences between these infections. In contrast with pandemic flu, the most frequent symptom of COVID-19 is thromboembolic complications. The examination of the autopsy material showed that, despite the large number of conducted studies, the morphofunctional state of the hematoalveolar barrier of the lungs has not been sufficiently studied and some mechanisms of the development of pathological reactions of the оrganism in response to the action of influenza viruses A(H1N1) pdm09 and SARS-CoV-2 remain unclear. But the post-mortem picture of the hematoalveolar barrier can allow us to see all previous links of the viral lung damage process. This, in turn, will help to solve the problem of timely diagnosis of the disease severity, prognosis, prevention of further development of the disease and appropriate methods of therapy. The purpose of the work was to study the features of the SARS-CoV-2 virus effect on the morphofunctional state of the hematoalveolar region of the lungs at autopsy, which allows the pathogenesis of COVID-19 to clarified, critical mechanisms, thedevelopment of which leads to fatal consequences, to be established, and a therapy strategy to be proposed. Materials and methods. 8 samples of autopsy material of the lungs of patients with COVID-19 were studied. The comparison groups were patients with pandemic influenza A caused by the H1N1 virus (3 autopsies) and lung samples obtained during surgery from a patient with traumatic pneumothorax at a distance from the main focus. Lung samples were processed according to standard methods of biological material preparation for electron microscopy. From the obtained blocks, semi-thin sections with a thickness of 1 μm were made. They were stained with methylene blue, and studied under a light microscope at a magnification of 500 times. Digital photographs were obtained from the most informative areas. Ultrathin sections were analyzed in electron microscope after being contrasted in uranium and lead salts. The incidence of thrombosis in the studied groups was calculated. Statistical processing was performed using the Fisher’s non-parametric exact test and the Biostat PC software package. Results. The conducted studies showed that patients with pandemic influenza A had a pronounced lesion of the alveolar part of the lungs with damage to the alveolar walls of the lungs and the appearance of hyaline membranes in them. Desquamated pneumocytes, erythrocytes, neutrophilic leukocytes, macrophages and fibrin clots were found in alveoli filled with serous fluid. Among the features of the influenza virus, the preservation of cellular elements in the alveolar walls, the convergence of the alveolar septums and the formation of large areas with a high level of neutrophilic and macrophage invasion should be noted. Macrophages patrol the fields of damaged alveolar septums, separating them from the surrounding tissue. The subsequent fibrotization indicates the replacement of the destroyed lung tissue. The group of patients with COVID-19, in contrast to the pandemic flu, has significantly higher rates of thrombosis of various calibers. This is the result of disseminated intravascular coagulation, which often leads to fatal consequences. Erythrocytes in vascular thrombi have a tendency to agglutination, which is more pronounced in oncological patients. For all studied cases, epithelial membrane damage is characterized by almost complete loss of epithelial cells, which is accompanied by the denudation of capillaries, in which there is an accumulation of erythrocytes that gives them the look of «blood sausages». Sometimes these vessels are attached to hyaline membranes, sometimes they are arranged in chains or groups. No significant neutrophilic invasion or granulomatous inflammation is observed. Conclusions. The conducted studies showed that patients with pandemic influenza A had a pronounced lesion of the alveolar part of the lungs with a high level of neutrophilic and macrophage invasion. The mechanisms of the pathogenesis of COVID-19 are the direct destructive effect of the virus on the epithelial cells of the hemato-alveolar barrier, which obviously leads to the release of inflammatory cytokines that stimulate the systemic reaction of intravascular coagulation. It has been established that for oncology patients with a history of chemotherapy, the processes of thrombosis and destruction of alveolar walls during COVID-19 were one of the most pronounced lesions among the patients. The obtained results suggest that the fatal consequences of COVID-19 can obviously be prevented if therapeutic measures aimed at destroying the virus, blocking the targets for its penetration into cells, breaking the chain of intravascular blood coagulation with the use of corticosteroids, anticoagulants, cytokine inhibitors, etc. are taken immediately after receiving a positive diagnosis for COVID-19 and carrying out a set of laboratory tests to assess the severity of the disease.


  • Open Access

    Survival of elderly patients with glioblastoma after hypofractionated radiation therapy

    by O.V. Zemskova, O.YA. Glavatskyi, A.B. Gryazov, V.A. Stulei, В.п. Старенький, А.о. Закрутько, О.я. Главацький

    Background. Glioblastoma (GB) is the most common primary brain tumor that is malignant, and its incidence increases with age. The prognosis for elderly patients with GB (GBe) is significantly worse than that of younger patients. Due to the global trend of aging population and age-related features of the GB cohort, the number of GBe patients is expected to increase. Although there is no full consensus regarding the clinical management of GBe, hypofractionated radiation therapy (RT) has become a common therapeutic option for elderly and/or poor prognosis GB patients. Purpose. To analyze the survival of patients with glioblastoma in the age group ≥60 years old after standard and hypofractionated regimens of adjuvant radiation therapy. Materials and methods. A retrospective single-center non-randomized study based on a total cohort of 53 patients (≥60 years old) with histogically verified diagnosis of GB was performed at the State Institution «Romodanov Neurosurgery Institute of the National Academy of Medical Sciences of Ukraine» over the period of 6 years, from 2014 to 2020. According to the RT regimen, patients were stratified into 2 groups: standard RT (SRT group) – 16 (30.2%) patients (30 fractions, 2.0 Gy per fraction, total radiation dose – 60.0 Gy) and hypofractionated RT (HRT group) – 37 (69.8%) patients (15 fractions, 3.5 Gy per fraction, total dose – 52.5 Gy). Cancer-specific survival (CSS) and progression-free survival (PFS) were analyzed in the total cohort and both groups separately. Results. With a median follow-up of 21.9 months (95% CI (confidence interval) 20.7 – 32.3), the median CSS in the total cohort was 15.0 (95% CI 13.3 – 17.3) months; the median PFS – 9.0 (95% CI 8.0 – 10.6) months. In the HRT group, the median CSS was 14.7 (95% CI 10.5 – 18.5) months; in the SRT group – 15.0 (95% CI 12.4 – 19.3) months. In the HRT group, the median PFS was 9.0 (95% CI 7.0 – 11.9) months; in the SRT group – 9.0 (95% CI 8.0 – 11.0) months. Before and after the stratification point of 15 months, the HRT and SRT groups did not differ significantly in CSS (Log-rank test p = 0.0588 and p = 0.2009, respectively). There was no significant difference in PFS between the HRT and SRT groups before and after the stratification point of 9 months (Log-rank test p = 0.0653 and p = 0.0722, respectively). Conclusions. Improving survival of GBe pts is an urgent issue, especially taking into account global trends in population aging and age-specific features of GB. The proposed hypofractionated RT regime can be considered as an optional approach in the complex treatment of GBe pts.